Glioblastoma multiforme (GBM) has a poor prognosis despite maximal multimodal therapy. Biomarkers of relevance to prognosis which may also identify treatment targets are needed …
D Hargrave - British journal of neurosurgery, 2009 - Taylor & Francis
Gliomas are the most common type of paediatric brain tumour and range from benign low grade gliomas which can be resected/observed to aggressive brainstem gliomas with dismal …
Y Ruano, T Ribalta, ÁR de Lope… - American journal of …, 2009 - academic.oup.com
Primary glioblastoma multiforme (GBM), in contrast with secondary GBM, has been associated with the presence of EGFR amplification and absence of p53 mutation. In this …
W Cao, L Xiong, L Meng, Z Li, Z Hu, H Lei, J Wu… - Heliyon, 2023 - cell.com
As many countries face an ageing population, the number of older patients with glioblastoma (GB) is increasing. Thus, there is an urgent need for prognostic models to aid …
S Jeswani, M Nuño, V Folkerts, D Mukherjee… - …, 2013 - journals.lww.com
BACKGROUND: Cerebellar glioblastoma multiforme (cGBM) is rare, and although there is a general belief that these tumors have a worse prognosis than supratentorial GBM (sGBM) …
T Picart, M Barritault, J Berthillier, D Meyronet… - Journal of neuro …, 2018 - Springer
Adult cerebellar glioblastomas (cGBM) are rare and their characteristics remain to be fully described. We analyzed the characteristics of 17 adult patients with cGBM and compared …
S Li, X Qiu, B Chen, W Zhang, R Huan… - Chinese medical …, 2009 - journals.lww.com
Background Glioblastoma multiforme (GBM) is the most malignant kind of astrocytic tumors and is associated with a poor prognosis. In this retrospective study, we assessed the clinical …
T Picart, D Poncet, M Barritault, L Bauchet… - The American Journal …, 2023 - journals.lww.com
Adult tumors diagnosed as cerebellar glioblastoma (cGBM) are rare and their optimal classification remains to be determined. The aim of this study was to identify subgroups of …
B Hong, R Banan, A Christians, M Nakamura… - Acta …, 2018 - Springer
Background Glioblastomas (GBM) are localized in only less than 1% of patients in the cerebellum. Therefore, tumor characteristics, survival, and the efficacy of therapies are not …